Table of Contents

1 Gamma Ray Imager Market Overview

• 1.1 Product Overview and Scope of Gamma Ray Imager
• 1.2 Gamma Ray Imager Segment by Type
  • 1.2.1 Global Gamma Ray Imager Sales Growth Rate Comparison by Type (2022-2028)
  • 1.2.2 Single Detector
  • 1.2.3 Dual Detector
• 1.3 Gamma Ray Imager Segment by Application
  • 1.3.1 Global Gamma Ray Imager Sales Comparison by Application: (2022-2028)
  • 1.3.2 for Cardiac Scintigraphy
  • 1.3.3 for Thyroid Scintigraphy
  • 1.3.4 for Mammography
  • 1.3.5 for Renal Scintigraphy
  • 1.3.6 for Whole Body Scan
• 1.4 Global Gamma Ray Imager Market Size Estimates and Forecasts
  • 1.4.1 Global Gamma Ray Imager Revenue 2017-2028
  • 1.4.2 Global Gamma Ray Imager Sales 2017-2028
  • 1.4.3 Gamma Ray Imager Market Size by Region: 2017 Versus 2021 Versus 2028

2 Gamma Ray Imager Market Competition by Manufacturers

• 2.1 Global Gamma Ray Imager Sales Market Share by Manufacturers (2017-2022)
• 2.2 Global Gamma Ray Imager Revenue Market Share by Manufacturers (2017-2022)
• 2.3 Global Gamma Ray Imager Average Price by Manufacturers (2017-2022)
• 2.4 Manufacturers Gamma Ray Imager Manufacturing Sites, Area Served, Product Type
• 2.5 Gamma Ray Imager Market Competitive Situation and Trends
  • 2.5.1 Gamma Ray Imager Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Gamma Ray Imager Players Market Share by Revenue
  • 2.5.3 Global Gamma Ray Imager Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gamma Ray Imager Retrospective Market Scenario by Region

• 3.1 Global Gamma Ray Imager Retrospective Market Scenario in Sales by Region: 2017-2022
• 3.2 Global Gamma Ray Imager Retrospective Market Scenario in Revenue by Region: 2017-2022
• 3.3 North America Gamma Ray Imager Market Facts & Figures by Country
  • 3.3.1 North America Gamma Ray Imager Sales by Country
  • 3.3.2 North America Gamma Ray Imager Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe Gamma Ray Imager Market Facts & Figures by Country
  • 3.4.1 Europe Gamma Ray Imager Sales by Country
  • 3.4.2 Europe Gamma Ray Imager Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Gamma Ray Imager Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Gamma Ray Imager Sales by Region
  • 3.5.2 Asia Pacific Gamma Ray Imager Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America Gamma Ray Imager Market Facts & Figures by Country
  • 3.6.1 Latin America Gamma Ray Imager Sales by Country
  • 3.6.2 Latin America Gamma Ray Imager Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
• 3.7 Middle East and Africa Gamma Ray Imager Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Gamma Ray Imager Sales by Country
  • 3.7.2 Middle East and Africa Gamma Ray Imager Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Gamma Ray Imager Historic Market Analysis by Type

• 4.1 Global Gamma Ray Imager Sales Market Share by Type (2017-2022)
• 4.2 Global Gamma Ray Imager Revenue Market Share by Type (2017-2022)
• 4.3 Global Gamma Ray Imager Price by Type (2017-2022)

5 Global Gamma Ray Imager Historic Market Analysis by Application

• 5.1 Global Gamma Ray Imager Sales Market Share by Application (2017-2022)
• 5.2 Global Gamma Ray Imager Revenue Market Share by Application (2017-2022)
• 5.3 Global Gamma Ray Imager Price by Application (2017-2022)

6 Key Companies Profiled

• 6.1 Digirad
  • 6.1.1 Digirad Corporation Information
  • 6.1.2 Digirad Description and Business Overview
  • 6.1.3 Digirad Gamma Ray Imager Sales, Revenue and Gross Margin (2017-2022)
  • 6.1.4 Digirad Gamma Ray Imager Product Portfolio
  • 6.1.5 Digirad Recent Developments/Updates
• 6.2 DDD-Diagnostic
  • 6.2.1 DDD-Diagnostic Corporation Information
  • 6.2.2 DDD-Diagnostic Description and Business Overview
  • 6.2.3 DDD-Diagnostic Gamma Ray Imager Sales, Revenue and Gross Margin (2017-2022)
  • 6.2.4 DDD-Diagnostic Gamma Ray Imager Product Portfolio
  • 6.2.5 DDD-Diagnostic Recent Developments/Updates
• 6.3 Spectrum Dynamics
  • 6.3.1 Spectrum Dynamics Corporation Information
  • 6.3.2 Spectrum Dynamics Description and Business Overview
  • 6.3.3 Spectrum Dynamics Gamma Ray Imager Sales, Revenue and Gross Margin (2017-2022)
  • 6.3.4 Spectrum Dynamics Gamma Ray Imager Product Portfolio
  • 6.3.5 Spectrum Dynamics Recent Developments/Updates
• 6.4 Mediso
  • 6.4.1 Mediso Corporation Information
  • 6.4.2 Mediso Description and Business Overview
  • 6.4.3 Mediso Gamma Ray Imager Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Mediso Gamma Ray Imager Product Portfolio
  • 6.4.5 Mediso Recent Developments/Updates
• 6.5 MIE America
  • 6.5.1 MIE America Corporation Information
  • 6.5.2 MIE America Description and Business Overview
  • 6.5.3 MIE America Gamma Ray Imager Sales, Revenue and Gross Margin (2017-2022)
  • 6.5.4 MIE America Gamma Ray Imager Product Portfolio
  • 6.5.5 MIE America Recent Developments/Updates
• 6.6 CardiArc
  • 6.6.1 CardiArc Corporation Information
  • 6.6.2 CardiArc Description and Business Overview
  • 6.6.3 CardiArc Gamma Ray Imager Sales, Revenue and Gross Margin (2017-2022)
  • 6.6.4 CardiArc Gamma Ray Imager Product Portfolio
  • 6.6.5 CardiArc Recent Developments/Updates
• 6.7 CLERAD
  • 6.6.1 CLERAD Corporation Information
  • 6.6.2 CLERAD Description and Business Overview
  • 6.6.3 CLERAD Gamma Ray Imager Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 CLERAD Gamma Ray Imager Product Portfolio
  • 6.7.5 CLERAD Recent Developments/Updates
• 6.8 Crystal Photonics
  • 6.8.1 Crystal Photonics Corporation Information
  • 6.8.2 Crystal Photonics Description and Business Overview
  • 6.8.3 Crystal Photonics Gamma Ray Imager Sales, Revenue and Gross Margin (2017-2022)
  • 6.8.4 Crystal Photonics Gamma Ray Imager Product Portfolio
  • 6.8.5 Crystal Photonics Recent Developments/Updates
• 6.9 Oncovision
  • 6.9.1 Oncovision Corporation Information
  • 6.9.2 Oncovision Description and Business Overview
  • 6.9.3 Oncovision Gamma Ray Imager Sales, Revenue and Gross Margin (2017-2022)
  • 6.9.4 Oncovision Gamma Ray Imager Product Portfolio
  • 6.9.5 Oncovision Recent Developments/Updates

7 Gamma Ray Imager Manufacturing Cost Analysis

• 7.1 Gamma Ray Imager Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Gamma Ray Imager
• 7.4 Gamma Ray Imager Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Gamma Ray Imager Distributors List
• 8.3 Gamma Ray Imager Customers

9 Gamma Ray Imager Market Dynamics

• 9.1 Gamma Ray Imager Industry Trends
• 9.2 Gamma Ray Imager Market Drivers
• 9.3 Gamma Ray Imager Market Challenges
• 9.4 Gamma Ray Imager Market Restraints

10 Global Market Forecast

• 10.1 Gamma Ray Imager Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Gamma Ray Imager by Type (2023-2028)
  • 10.1.2 Global Forecasted Revenue of Gamma Ray Imager by Type (2023-2028)
• 10.2 Gamma Ray Imager Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Gamma Ray Imager by Application (2023-2028)
  • 10.2.2 Global Forecasted Revenue of Gamma Ray Imager by Application (2023-2028)
• 10.3 Gamma Ray Imager Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Gamma Ray Imager by Region (2023-2028)
  • 10.3.2 Global Forecasted Revenue of Gamma Ray Imager by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List

Summary:

Industry Insights
Due to the COVID-19 pandemic, the global Gamma Ray Imager market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Gamma Ray Imager market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Gamma Ray Imager landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Single Detector accounting for % of the Gamma Ray Imager global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While for Cardiac Scintigraphy segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Gamma Ray Imager include Digirad, DDD-Diagnostic, Spectrum Dynamics, Mediso, MIE America, CardiArc, CLERAD, Crystal Photonics and Oncovision. etc. In terms of revenue, the global 3 largest players have a % market share of Gamma Ray Imager in 2021.
This report focuses on Gamma Ray Imager volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Gamma Ray Imager market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Post-covid-19 Outlook
The readers in the section will understand how the Gamma Ray Imager market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Segmental Outlook
Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
Segment by Type
Single Detector
Dual Detector
Segment by Application
for Cardiac Scintigraphy
for Thyroid Scintigraphy
for Mammography
for Renal Scintigraphy
for Whole Body Scan
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Scenario
In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Digirad
DDD-Diagnostic
Spectrum Dynamics
Mediso
MIE America
CardiArc
CLERAD
Crystal Photonics
Oncovision
Frequently Asked Questions
Which product segment grabbed the largest share in the Gamma Ray Imager market?
How is the competitive scenario of the Gamma Ray Imager market?
Which are the key factors aiding the Gamma Ray Imager market growth?
Which are the prominent players in the Gamma Ray Imager market?
Which region holds the maximum share in the Gamma Ray Imager market?
What will be the CAGR of the Gamma Ray Imager market during the forecast period?
Which application segment emerged as the leading segment in the Gamma Ray Imager market?
What key trends are likely to emerge in the Gamma Ray Imager market in the coming years?
What will be the Gamma Ray Imager market size by 2028?
Which company held the largest share in the Gamma Ray Imager market?